Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Nov;64(5):953–955. doi: 10.1038/bjc.1991.433

Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?

N J Bundred 1, R R West 1, J O Dowd 1, R E Mansel 1, L E Hughes 1
PMCID: PMC1977475  PMID: 1931623

Abstract

A consecutive series of 644 women who presented with breast nodularity between 1976 and 1982 have been followed up to determine their rate of subsequent breast cancer. Fifteen women have developed breast cancer, 14 of these were among 352 women with an aspirated cyst (relative risk 4.4). Women with multiple cysts had the highest risk and women with breast nodularity had no excess risk. Review of histology specimens from those women who had undergone biopsy showed an excess of florid epithelial hyperplasia in women who subsequently developed breast cancer and women with multiple aspirated cysts were more likely to have florid epithelial hyperplasia. Multiple cysts are clinical markers of histological breast proliferation and women who have had multiple breast cysts aspirated have an increased risk of breast cancer and should be advised to practice regular self examination.

Full text

PDF
953

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DAVIS H. H., SIMONS M., DAVIS J. B. CYSTIC DISEASE OF THE BREAST: RELATIONSHIP TO CARCINOMA. Cancer. 1964 Aug;17:957–978. doi: 10.1002/1097-0142(196408)17:8<957::aid-cncr2820170802>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  2. Dhont M., Delbeke L., van Eyck J., Voorhoof L. Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation. Postgrad Med J. 1979;55 (Suppl 5):66–70. [PubMed] [Google Scholar]
  3. Dupont W. D., Page D. L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146–151. doi: 10.1056/NEJM198501173120303. [DOI] [PubMed] [Google Scholar]
  4. Haagensen D. E., Jr, Mazoujian G., Dilley W. G., Pedersen C. E., Kister S. J., Wells S. A., Jr Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J Natl Cancer Inst. 1979 Feb;62(2):239–247. [PubMed] [Google Scholar]
  5. Hughes L. E., Mansel R. E., Webster D. J. Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet. 1987 Dec 5;2(8571):1316–1319. doi: 10.1016/s0140-6736(87)91204-9. [DOI] [PubMed] [Google Scholar]
  6. Jones B. M., Bradbeer J. W. The presentation and progress of macroscopic breast cysts. Br J Surg. 1980 Sep;67(9):669–671. doi: 10.1002/bjs.1800670922. [DOI] [PubMed] [Google Scholar]
  7. Miller W. R., Dixon J. M., Scott W. N., Forrest A. P. Classification of human breast cysts according to electrolyte and androgen conjugate composition. Clin Oncol. 1983 Sep;9(3):227–232. [PubMed] [Google Scholar]
  8. Page D. L., Vander Zwaag R., Rogers L. W., Williams L. T., Walker W. E., Hartmann W. H. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst. 1978 Oct;61(4):1055–1063. [PubMed] [Google Scholar]
  9. Roberts M. M., Jones V., Elton R. A., Fortt R. W., Williams S., Gravelle I. H. Risk of breast cancer in women with history of benign disease of the breast. Br Med J (Clin Res Ed) 1984 Jan 28;288(6413):275–278. doi: 10.1136/bmj.288.6413.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sims A. C. Importance of a high tracing-rate in long-term medical follow-up studies. Lancet. 1973 Aug 25;2(7826):433–435. doi: 10.1016/s0140-6736(73)92287-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES